Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples